Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-17-014889
Filing Date
2017-12-21
Accepted
2017-12-20 19:52:49
Documents
86
Period of Report
2017-10-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1996217
2 image_009.jpg GRAPHIC 32487
3 image_006.jpg GRAPHIC 4581
4 image_008.jpg GRAPHIC 23251
5 image_010.jpg GRAPHIC 39643
6 ex23-1.htm EX-23.1 4926
7 ex31-1.htm EX-31.1 20250
8 ex31-2.htm EX-31.2 20912
9 ex32-1.htm EX-32.1 7030
10 ex32-2.htm EX-32.2 7069
  Complete submission text file 0001493152-17-014889.txt   6417845

Data Files

Seq Description Document Type Size
11 XBRL INSTANCE FILE adxs-20171031.xml EX-101.INS 980168
12 XBRL SCHEMA FILE adxs-20171031.xsd EX-101.SCH 64421
13 XBRL CALCULATION FILE adxs-20171031_cal.xml EX-101.CAL 79969
14 XBRL DEFINITION FILE adxs-20171031_def.xml EX-101.DEF 179388
15 XBRL LABEL FILE adxs-20171031_lab.xml EX-101.LAB 436923
16 XBRL PRESENTATION FILE adxs-20171031_pre.xml EX-101.PRE 320837
Mailing Address 305 COLLEGE ROAD EAST PRINCETON, NJ 08540
Business Address 305 COLLEGE ROAD EAST PRINCETON, NJ 08540 732 545 1590
Advaxis, Inc. (Filer) CIK: 0001100397 (see all company filings)

EIN.: 841521955 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 10-K | Act: 34 | File No.: 001-36138 | Film No.: 171267825
SIC: 2834 Pharmaceutical Preparations